Stay updated on Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial page.

Latest updates to the Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov page footer shows an updated site revision, from v3.7.2 to v3.8.0. The study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoChange DetectedA site-wide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the study page.SummaryDifference1%

- Check18 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov 403 error page.SummaryDifference0.2%

- Check25 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check46 days agoChange DetectedThe study record page now displays a 403 Forbidden error with a minimal header and a Home link. A large portion of data-sharing and related information was removed from the page.SummaryDifference18%

- Check67 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing Revision: v3.6.5. This indicates a recent UI/content update to the page.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib Combo with Topical Steroids in Atopic Dermatitis Clinical Trial page.